Empagliflozin 25 mg Tablet (Empagliflozin)

Adult dose

The recommended dose of this medication is 10 mg once daily. If additional blood sugar control is needed with good tolerability, it may be increased to 25 mg once daily. This medication can be taken irrespective of meals and the tablet should be swallowed whole. If a dose is missed, it should be taken as soon as remembered, but do not take two doses in one day.

This medication should not be used in patients with a known allergy to the active ingredient or any of its components. It is not to be administered in patients with Type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired renal function, end-stage renal disease, or those on dialysis should not use this medication. It should not be used in patients with a genetic disorder that prevents lactose breakdown. Patients with mildly impaired renal function should use this medication with caution, and dosage adjustments or discontinuation may be necessary. Some patients with heart failure may require careful monitoring due to the lack of safety data. If taken with medications that pose a risk of hypoglycemia, such as insulin or sulfonylureas, dosage adjustments may be necessary to reduce the risk of hypoglycemia. Adverse effects may include hypoglycemia, urinary tract infections, genital infections, increased urination, dehydration, hypotension, and liver function abnormalities. Particularly, elderly patients or those at risk of fluid loss should be cautious of dehydration symptoms. This medication can cause a serious metabolic disorder called ketoacidosis, so if symptoms appear, immediate consultation with healthcare professionals is required. Due to potential liver damage, caution should be exercised if liver function abnormalities are present. Moreover, the risk of urinary and genital infections may be increased, so appropriate treatment is necessary if infection symptoms occur. This medication may affect lithium levels in the blood, so patients taking lithium should frequently monitor their blood levels. Pregnant women are advised not to use this medication, and it should also be avoided during breastfeeding. Safety and efficacy in pediatric patients under 18 years of age have not been established. There are no specific toxic symptoms reported in case of overdose, but appropriate medical intervention should be sought in the event of an overdose. This medication should be stored out of the reach of children and it is important not to transfer it to another container to maintain product quality.

Serious side effects

• Urticaria
• angioedema
• ketoacidosis
• urosepsis
• pyelonephritis
• rash
• perineal necrosis
• severe metabolic acidosis
• nausea
• vomiting

Mild side effects

• Hypoglycemia
• diarrhea
• nausea
• gastric ulcer
• colitis
• vomiting
• ischemic colitis
• colon bleeding
• vaginitis
• vulvitis

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

A pale yellow, oval, biconvex, film-coated tablet

Package unit

30 tablets/bottle